Actively Recruiting
Candida PCR Diagnosis Strategy in Patients From Intensive Care Units
Led by University Hospital, Toulouse · Updated on 2024-08-02
120
Participants Needed
1
Research Sites
167 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to evaluate the implementation of a new technique for invasive candidiasis diagnosis by PCR. The main objective will be to evaluate the effect of this strategy on the time required to obtain results in patients from intensive care units with suspected systemic invasive candidiasis. This PCR method could allow an antifungal switch to be made earlier, limiting the appearance of resistance and reducing the cost of antifungals for healthcare facilities.
CONDITIONS
Official Title
Candida PCR Diagnosis Strategy in Patients From Intensive Care Units
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient affiliated or benefiting from a social protection system
- Patient (or trusted person) has given free and informed written consent
- Non-neutropenic patient hospitalized in Toulouse University Hospital ICU
- Suspected invasive candidiasis with blood culture taken and empirical echinocandin treatment at adapted dose
You will not qualify if you...
- Patients under guardianship or trusteeship, or court protection
- Pregnant or breastfeeding patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Uh Toulouse
Toulouse, Occitanie, France, 31000
Actively Recruiting
Research Team
P
Pamela CHAUVIN
CONTACT
X
Xavier IRIART
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here